Efficacy of Co-enzyme Q-10 (Ubiquinone) in geriatrics community-acquired pneumonia
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Sep 2016
Price : $35 *
At a glance
- Drugs Ubidecarenone (Primary) ; Azithromycin; Ceftriaxone
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- 20 Jan 2014 Status changed from recruiting to active, no longer recruiting as per Iranian Registry of Clinical Trials record.
- 20 Jan 2014 Recruitment was completed on 15 November 2013 as per Iranian Registry of Clinical Trials record.
- 16 Aug 2013 Recruitment expected to complete on 15 November 2013.